SCHEMBL7986235

SCHEMBL7986235

CC(C)(C)c1cc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)cc(C(C)(C)C)c1O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 1/20 0.52
KMT2A Q03164 1/20 0.48
CNOT7 Q9UIV1 2/20 0.40
PARN O95453 1/20 0.40
GAA P10253 1/20 0.40
BRD4 O60885 1/20 0.40
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
MAOB P27338 2/20 0.39
PNP P00491 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
ADORA2B P29275 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
BCHE P06276 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984883 0.87 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL8056958 0.87 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7988680 0.86 HPGD (0.46) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7988785 0.85 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7985321 0.84 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7986239 0.84 CNOT7 (0.47) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7975265 0.83 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7988556 0.82 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7984948 0.81 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2ACNOT7
SCHEMBL7974486 0.81 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1HPGDKMT2ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed